|
National Cancer Institute
Principal Investigator – Judith Walsh, MD, MPH
UCSF CRN Co-Investigator – Michael Potter, MD
The project will develop and test an interactive video program for use with patients in waiting rooms in a variety of outpatient primary care settings. The program will educate patients and encourage them to get breast, cervical, and colorectal cancer when indicated. The outpatient settings will be drawn from the diverse membership of the UCSF Collaborative Research Network (CRN) a practice-based research network coordinated by the Department of Family and Community Medicine at UCSF.

Alexander and Margaret Stewart Trust
Principal Investigator – Michael Potter, MD
Co-Principal Investigator – Lisa Kroon, PharmD
This pilot project will compare outcomes when eligible pharmacy customers are offered information about colorectal cancer screening versus a home fecal immunochemical test (FIT) within the context of annual Walgreens Pharmacy influenza vaccination clinics. Patients who receive FIT will mail the completed kits to Quest Diagnostics and results will be sent to the patient and to their primary care physician. Patients and pharmacists will be interviewed at the conclusion of the study to understand the feasibility of each intervention arm.

American Cancer Society
Principal Investigator – Michael Potter, MD
Co-Principal Investigator – Carol Somkin, PhD
UCSF Co-Investigators – Judith Walsh, MD, MPH; Stephen McPhee, MD; Lawrence W. Green DrPH
This is a 4-year dissemination and implementation study of the provision of fecal immunochemical tests in the context of annual influenza vaccination campaigns within Kaiser Permanente Northern California service areas. The work will incorporate a pilot phase at Kaiser Permanente Santa Clara, a time-randomized intervention at 4 additional service areas, a diffusion intervention across all of Kaiser Permanente Northern California, and evaluation using the RE-AIM framework (reach, effectiveness, adoption, implementation, and maintenance). This project builds of pilot work at Kaiser Permanente Northern California funded by the National Institutes of Health’s HMO Cancer Research Network.

Centers for Disease Control and Prevention
Principal Investigator – Michael Potter, MD
UCSF Co-Investigators – Judith Walsh, MD, MPH, Stephen McPhee, MD; Lawrence W. Green DrPH
This is a 3-year dissemination and implementation study of the provision of fecal occult blood tests in the context of annual influenza vaccination campaign within the San Francisco Department of Public Health. The work will incorporate a pilot phase at Chinatown Public Health Center and a time-randomized intervention at 6 additional public health clinics in San Francisco, and evaluation using the RE-AIM framework (reach, effectiveness, adoption, implementation, and maintenance). This project builds of pilot work at San Francisco General Hospital funded by the American Cancer Society.

|